Impact Story: Using innovative statistical approaches to provide the most reliable treatment outcomes information to patients and clinicians | FDA

Impact Story: Using innovative statistical approaches to provide the most reliable treatment outcomes information to patients and clinicians | FDA

Using Bayesian hierarchical models, CDER statisticians are improving our understanding of how drugs affect different groups of patients.

When evaluating drug treatments, determining how and to what extent a drug works in different patient subgroups can be addressed by statistical approaches that make use of results from every subgroup when understanding the treatment effect for a given subgroup. 

To learn more, please visit: FDA CDER Impact Story.